Health Care Providers' Views on Clinic Infrastructure and Practice Models That May Facilitate HIV Preexposure Prophylaxis (PrEP) Prescribing: A Qualitative Meta-Synthesis.
HIV preexposure prophylaxis (PrEP)
HIV/AIDS
access to care
clinic infrastructure
environmental and systems change
health care providers
practice models
prescribing
Journal
Health promotion practice
ISSN: 1524-8399
Titre abrégé: Health Promot Pract
Pays: United States
ID NLM: 100890609
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
pubmed:
23
9
2021
medline:
3
12
2022
entrez:
22
9
2021
Statut:
ppublish
Résumé
HIV (human immunodeficiency virus) preexposure prophylaxis (PrEP) is an effective biomedical HIV prevention tool. Increasing PrEP use among populations disproportionately affected by HIV is one of the key efforts in the United States' Ending the HIV Epidemic (EHE) initiative and the HIV National Strategic Plan for the United States. Given that PrEP is available only through prescription, it is important to explore structural, organizational, or environmental factors that could facilitate or impede health care provider's PrEP prescribing behavior. The purpose of this systematic review (PROSPERO [CRD: 42019138889]) is to identify qualitative studies that addressed this topic and conduct meta-synthesis using the thematic synthesis method to identify major themes on the characteristics of clinic infrastructure or clinic models that providers consider as facilitators of PrEP prescribing in the United States. Eighteen citations representing 15 studies were included in this review. Five overarching themes were identified: (1) routinized HIV risk assessment; (2) interdisciplinary/coordinated PrEP teams or services; (3) clinic capacity to provide essential PrEP-related services; (4) low out-of-pocket patient costs; and (5) access to the priority populations. Some of these themes are consistent with the recommendations of CDC's PrEP clinical guidelines and the EHE initiative. More recent studies that include perspectives of diverse providers, timely analysis of these studies, and implementation research to assess strategies to address the current practice gaps are needed to further promote PrEP prescribing among providers in the United States.
Identifiants
pubmed: 34549652
doi: 10.1177/15248399211038364
pmc: PMC8938291
mid: NIHMS1759118
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
999-1014Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States